Heatwurx (PCSA) Competitors $0.30 -0.02 (-5.84%) Closing price 10/21/2025 04:00 PM EasternExtended Trading$0.26 -0.04 (-13.97%) As of 07:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock PCSA vs. ALGS, CUE, GNTA, ANL, MNOV, OTLK, ELYM, ACRV, SNTI, and JATTShould you be buying Heatwurx stock or one of its competitors? The main competitors of Heatwurx include Aligos Therapeutics (ALGS), Cue Biopharma (CUE), Genenta Science (GNTA), Adlai Nortye (ANL), MediciNova (MNOV), Oncobiologics (OTLK), Eliem Therapeutics (ELYM), Acrivon Therapeutics (ACRV), Senti Biosciences (SNTI), and JATT Acquisition (JATT). These companies are all part of the "pharmaceutical products" industry. Heatwurx vs. Its Competitors Aligos Therapeutics Cue Biopharma Genenta Science Adlai Nortye MediciNova Oncobiologics Eliem Therapeutics Acrivon Therapeutics Senti Biosciences JATT Acquisition Aligos Therapeutics (NASDAQ:ALGS) and Heatwurx (NASDAQ:PCSA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Which has higher valuation & earnings, ALGS or PCSA? Heatwurx has lower revenue, but higher earnings than Aligos Therapeutics. Aligos Therapeutics is trading at a lower price-to-earnings ratio than Heatwurx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAligos Therapeutics$3.94M16.37-$131.21M-$19.79-0.53HeatwurxN/AN/A-$11.85M-$2.32-0.13 Is ALGS or PCSA more profitable? Heatwurx has a net margin of 0.00% compared to Aligos Therapeutics' net margin of -2,337.24%. Aligos Therapeutics' return on equity of -22.41% beat Heatwurx's return on equity.Company Net Margins Return on Equity Return on Assets Aligos Therapeutics-2,337.24% -22.41% -12.09% Heatwurx N/A -342.36%-243.48% Do insiders & institutionals have more ownership in ALGS or PCSA? 60.4% of Aligos Therapeutics shares are held by institutional investors. Comparatively, 91.9% of Heatwurx shares are held by institutional investors. 4.8% of Aligos Therapeutics shares are held by company insiders. Comparatively, 2.4% of Heatwurx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts rate ALGS or PCSA? Aligos Therapeutics presently has a consensus price target of $50.00, suggesting a potential upside of 376.64%. Heatwurx has a consensus price target of $1.00, suggesting a potential upside of 233.44%. Given Aligos Therapeutics' higher possible upside, equities analysts plainly believe Aligos Therapeutics is more favorable than Heatwurx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aligos Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Heatwurx 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to ALGS or PCSA? In the previous week, Aligos Therapeutics had 2 more articles in the media than Heatwurx. MarketBeat recorded 3 mentions for Aligos Therapeutics and 1 mentions for Heatwurx. Aligos Therapeutics' average media sentiment score of 0.24 beat Heatwurx's score of -1.00 indicating that Aligos Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Aligos Therapeutics Neutral Heatwurx Negative Which has more volatility and risk, ALGS or PCSA? Aligos Therapeutics has a beta of 2.77, suggesting that its stock price is 177% more volatile than the S&P 500. Comparatively, Heatwurx has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500. SummaryAligos Therapeutics beats Heatwurx on 8 of the 13 factors compared between the two stocks. Get Heatwurx News Delivered to You Automatically Sign up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PCSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PCSA vs. The Competition Export to ExcelMetricHeatwurxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.04M$3.01B$6.22B$10.67BDividend YieldN/A57.78%5.74%4.88%P/E Ratio-0.1323.5929.1427.23Price / SalesN/A786.13589.44132.72Price / CashN/A171.3937.5161.65Price / Book0.655.4112.566.59Net Income-$11.85M$33.06M$3.32B$276.14M7 Day Performance-26.82%-0.68%0.73%-0.72%1 Month Performance51.77%8.13%7.29%2.47%1 Year Performance-77.62%-2.15%65.05%33.90% Heatwurx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PCSAHeatwurx2.4699 of 5 stars$0.30-5.8%$1.00+233.4%-78.7%$16.04MN/A-0.1320Negative NewsUpcoming EarningsShort Interest ↑Gap DownALGSAligos Therapeutics3.9202 of 5 stars$10.44+4.5%$50.00+378.9%+43.9%$61.45M$3.94M-0.5390CUECue Biopharma2.2262 of 5 stars$0.82+3.1%N/A-50.9%$61.19M$9.29M-1.4760GNTAGenenta ScienceN/A$3.20+0.6%N/A-38.5%$60.82MN/A0.007ANLAdlai Nortye1.2619 of 5 stars$1.65+0.6%$9.00+445.5%-15.1%$60.52M$5M0.00127News CoverageShort Interest ↑Gap UpMNOVMediciNova1.7784 of 5 stars$1.21-1.6%$7.00+478.5%-31.5%$60.33M$134.60K-4.8410OTLKOncobiologics2.8089 of 5 stars$1.48+13.0%$7.00+373.0%-75.2%$58.19MN/A-2.6020Positive NewsGap DownELYMEliem TherapeuticsN/A$1.93-1.0%N/A-53.8%$57.42MN/A-3.649Gap UpACRVAcrivon Therapeutics2.3547 of 5 stars$1.92+6.1%$15.00+681.3%-74.7%$56.94MN/A-0.8558News CoverageSNTISenti Biosciences3.4029 of 5 stars$2.14-0.5%$9.67+351.7%-9.3%$56.24MN/A-0.244JATTJATT AcquisitionN/A$3.21-6.4%N/A-31.5%$55.37MN/A0.003High Trading Volume Related Companies and Tools Related Companies Aligos Therapeutics Alternatives Cue Biopharma Alternatives Genenta Science Alternatives Adlai Nortye Alternatives MediciNova Alternatives Oncobiologics Alternatives Eliem Therapeutics Alternatives Acrivon Therapeutics Alternatives Senti Biosciences Alternatives JATT Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PCSA) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredThe Republican party is falling apartSomething unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heatwurx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heatwurx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCSA Stock Alerts